3fj6 - Revision history

OCA at 15:29, 1 November 2023

2023-11-01T15:29:57Z

←Older revision		Revision as of 15:29, 1 November 2023
Line 3:		Line 3:
	<StructureSection load='3fj6' size='340' side='right'caption='[[3fj6]], [[Resolution\|resolution]] 1.80Å' scene=''>		<StructureSection load='3fj6' size='340' side='right'caption='[[3fj6]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[3fj6]] is a 1 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=3FJ6 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[3fj6]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3FJ6 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CIH:(2Z)-2-CYANO-N-(2,2-DICHLOROBIPHENYL-4-YL)-3-HYDROXYBUT-2-ENAMIDE'>CIH</scene>, <scene name='pdbligand=FMN:FLAVIN+MONONUCLEOTIDE'>FMN</scene>, <scene name='pdbligand=ORO:OROTIC+ACID'>ORO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene~~></td></tr>~~	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.8Å</td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3f1q\|3f1q]], [[3fjl\|3fjl]]</td></tr>~~	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CIH:(2Z)-2-CYANO-N-(2,2-DICHLOROBIPHENYL-4-YL)-3-HYDROXYBUT-2-ENAMIDE'>CIH</scene>, <scene name='pdbligand=FMN:FLAVIN+MONONUCLEOTIDE'>FMN</scene>, <scene name='pdbligand=ORO:OROTIC+ACID'>ORO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Dihydroorotate_oxidase_(fumarate) Dihydroorotate oxidase (fumarate)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.98.1 1.3.98.1] </span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3fj6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fj6 OCA], [https://pdbe.org/3fj6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3fj6 RCSB], [https://www.ebi.ac.uk/pdbsum/3fj6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3fj6 ProSAT]</span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=3fj6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fj6 OCA], [~~http~~://pdbe.org/3fj6 PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=3fj6 RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/3fj6 PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=3fj6 ProSAT]</span></td></tr>	+
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Defects in DHODH are the cause of postaxial acrofacial dysostosis (POADS) [MIM:[~~http~~://omim.org/entry/263750 263750]]; also known as Miller syndrome. POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.<ref>PMID:19915526</ref>	+	[https://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN] Defects in DHODH are the cause of postaxial acrofacial dysostosis (POADS) [MIM:[https://omim.org/entry/263750 263750]; also known as Miller syndrome. POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.<ref>PMID:19915526</ref>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.	+	[https://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN] Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.
	== Evolutionary Conservation ==		== Evolutionary Conservation ==
	[[Image:Consurf_key_small.gif\|200px\|right]]		[[Image:Consurf_key_small.gif\|200px\|right]]
Line 39:		Line 38:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Heikkila, T]]	+	[[Category: Heikkila T]]
-	~~[[Category: Alpha-beta barrel tim barrel]]~~	+
-	~~[[Category: Fad]]~~	+
-	~~[[Category: Flavoprotein]]~~	+
-	~~[[Category: Membrane]]~~	+
-	~~[[Category: Mitochondrion]]~~	+
-	~~[[Category: Mitochondrion inner membrane]]~~	+
-	~~[[Category: Oxidoreductase]]~~	+
-	~~[[Category: Polymorphism]]~~	+
-	~~[[Category: Pyrimidine biosynthesis]]~~	+
-	~~[[Category: Transit peptide~~]]	+

OCA at 10:30, 9 September 2020

2020-09-09T10:30:40Z

←Older revision		Revision as of 10:30, 9 September 2020
Line 1:		Line 1:

	==Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2==		==Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2==
-	<StructureSection load='3fj6' size='340' side='right' caption='[[3fj6]], [[Resolution\|resolution]] 1.80Å' scene=''>	+	<StructureSection load='3fj6' size='340' side='right'caption='[[3fj6]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[3fj6]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=3FJ6 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[3fj6]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=3FJ6 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CIH:(2Z)-2-CYANO-N-(2,2-DICHLOROBIPHENYL-4-YL)-3-HYDROXYBUT-2-ENAMIDE'>CIH</scene>, <scene name='pdbligand=FMN:FLAVIN+MONONUCLEOTIDE'>FMN</scene>, <scene name='pdbligand=ORO:OROTIC+ACID'>ORO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CIH:(2Z)-2-CYANO-N-(2,2-DICHLOROBIPHENYL-4-YL)-3-HYDROXYBUT-2-ENAMIDE'>CIH</scene>, <scene name='pdbligand=FMN:FLAVIN+MONONUCLEOTIDE'>FMN</scene>, <scene name='pdbligand=ORO:OROTIC+ACID'>ORO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3f1q\|3f1q]], [[3fjl\|3fjl]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3f1q\|3f1q]], [[3fjl\|3fjl]]</td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Dihydroorotate_oxidase_(fumarate) Dihydroorotate oxidase (fumarate)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.98.1 1.3.98.1] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Dihydroorotate_oxidase_(fumarate) Dihydroorotate oxidase (fumarate)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.98.1 1.3.98.1] </span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=3fj6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fj6 OCA], [http://pdbe.org/3fj6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3fj6 RCSB], [http://www.ebi.ac.uk/pdbsum/3fj6 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3fj6 ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=3fj6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fj6 OCA], [http://pdbe.org/3fj6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3fj6 RCSB], [http://www.ebi.ac.uk/pdbsum/3fj6 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3fj6 ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 34:		Line 34:

	==See Also==		==See Also==
-	*[[Dihydroorotate dehydrogenase\|Dihydroorotate dehydrogenase]]	+	*[[Dihydroorotate dehydrogenase 3D structures\|Dihydroorotate dehydrogenase 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
Line 40:		Line 40:
	</StructureSection>		</StructureSection>
	[[Category: Human]]		[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Heikkila, T]]		[[Category: Heikkila, T]]
	[[Category: Alpha-beta barrel tim barrel]]		[[Category: Alpha-beta barrel tim barrel]]

OCA at 07:40, 5 December 2018

2018-12-05T07:40:28Z

←Older revision		Revision as of 07:40, 5 December 2018
Line 1:		Line 1:
		+
	==Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2==		==Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2==
	<StructureSection load='3fj6' size='340' side='right' caption='[[3fj6]], [[Resolution\|resolution]] 1.80Å' scene=''>		<StructureSection load='3fj6' size='340' side='right' caption='[[3fj6]], [[Resolution\|resolution]] 1.80Å' scene=''>
Line 6:		Line 7:
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3f1q\|3f1q]], [[3fjl\|3fjl]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3f1q\|3f1q]], [[3fjl\|3fjl]]</td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Dihydroorotate_oxidase_(fumarate) Dihydroorotate oxidase (fumarate)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.98.1 1.3.98.1] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Dihydroorotate_oxidase_(fumarate) Dihydroorotate oxidase (fumarate)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.98.1 1.3.98.1] </span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3fj6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fj6 OCA], [http://pdbe.org/3fj6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3fj6 RCSB], [http://www.ebi.ac.uk/pdbsum/3fj6 PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3fj6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fj6 OCA], [http://pdbe.org/3fj6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3fj6 RCSB], [http://www.ebi.ac.uk/pdbsum/3fj6 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3fj6 ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 16:		Line 17:
	Check<jmol>		Check<jmol>
	<jmolCheckbox>		<jmolCheckbox>
-	<scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/fj/3fj6_consurf.spt"</scriptWhenChecked>	+	<scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/fj/3fj6_consurf.spt"</scriptWhenChecked>
	<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>		<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
	<text>to colour the structure by Evolutionary Conservation</text>		<text>to colour the structure by Evolutionary Conservation</text>
Line 47:		Line 48:
	[[Category: Mitochondrion inner membrane]]		[[Category: Mitochondrion inner membrane]]
	[[Category: Oxidoreductase]]		[[Category: Oxidoreductase]]
		+	[[Category: Polymorphism]]
	[[Category: Pyrimidine biosynthesis]]		[[Category: Pyrimidine biosynthesis]]
	[[Category: Transit peptide]]		[[Category: Transit peptide]]

OCA at 00:48, 8 February 2016

2016-02-08T00:48:10Z

←Older revision		Revision as of 00:48, 8 February 2016
Line 2:		Line 2:
	<StructureSection load='3fj6' size='340' side='right' caption='[[3fj6]], [[Resolution\|resolution]] 1.80Å' scene=''>		<StructureSection load='3fj6' size='340' side='right' caption='[[3fj6]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[3fj6]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/~~Homo_sapiens Homo sapiens~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3FJ6 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[3fj6]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3FJ6 FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CIH:(2Z)-2-CYANO-N-(2,2-DICHLOROBIPHENYL-4-YL)-3-HYDROXYBUT-2-ENAMIDE'>CIH</scene>, <scene name='pdbligand=FMN:FLAVIN+MONONUCLEOTIDE'>FMN</scene>, <scene name='pdbligand=ORO:OROTIC+ACID'>ORO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CIH:(2Z)-2-CYANO-N-(2,2-DICHLOROBIPHENYL-4-YL)-3-HYDROXYBUT-2-ENAMIDE'>CIH</scene>, <scene name='pdbligand=FMN:FLAVIN+MONONUCLEOTIDE'>FMN</scene>, <scene name='pdbligand=ORO:OROTIC+ACID'>ORO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3f1q\|3f1q]], [[3fjl\|3fjl]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3f1q\|3f1q]], [[3fjl\|3fjl]]</td></tr>
-	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/~~Dihydroorotate_oxidase~~ Dihydroorotate oxidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.3.1 1.3.3.1] </span></td></tr>	+	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Dihydroorotate_oxidase_(fumarate) Dihydroorotate oxidase (fumarate)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.98.1 1.3.98.1] </span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3fj6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fj6 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3fj6 RCSB], [http://www.ebi.ac.uk/pdbsum/3fj6 PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3fj6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fj6 OCA], [http://pdbe.org/3fj6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3fj6 RCSB], [http://www.ebi.ac.uk/pdbsum/3fj6 PDBsum]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 20:		Line 20:
	<text>to colour the structure by Evolutionary Conservation</text>		<text>to colour the structure by Evolutionary Conservation</text>
	</jmolCheckbox>		</jmolCheckbox>
-	</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary\|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/~~chain_selection~~.php?pdb_ID=~~2ata~~ ConSurf].	+	</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary\|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=3fj6 ConSurf].
	<div style="clear:both"></div>		<div style="clear:both"></div>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 30:		Line 30:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 3fj6" style="background-color:#fffaf0;"></div>

	==See Also==		==See Also==
Line 37:		Line 38:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Dihydroorotate oxidase]]~~	+	[[Category: Human]]
-	~~[[Category: Homo sapiens~~]]	+
	[[Category: Heikkila, T]]		[[Category: Heikkila, T]]
	[[Category: Alpha-beta barrel tim barrel]]		[[Category: Alpha-beta barrel tim barrel]]

OCA at 13:46, 18 December 2014

2014-12-18T13:46:35Z

←Older revision		Revision as of 13:46, 18 December 2014
Line 1:		Line 1:
-	~~{{STRUCTURE_3fj6\| PDB=3fj6 \| SCENE= }}~~	+	==Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2==
-	===Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2===	+	<StructureSection load='3fj6' size='340' side='right' caption='[[3fj6]], [[Resolution\|resolution]] 1.80Å' scene=''>
-	~~{{ABSTRACT_PUBMED_19351152}}~~	+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[3fj6]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3FJ6 FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CIH:(2Z)-2-CYANO-N-(2,2-DICHLOROBIPHENYL-4-YL)-3-HYDROXYBUT-2-ENAMIDE'>CIH</scene>, <scene name='pdbligand=FMN:FLAVIN+MONONUCLEOTIDE'>FMN</scene>, <scene name='pdbligand=ORO:OROTIC+ACID'>ORO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3f1q\|3f1q]], [[3fjl\|3fjl]]</td></tr>
		+	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Dihydroorotate_oxidase Dihydroorotate oxidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.3.1 1.3.3.1] </span></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3fj6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fj6 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3fj6 RCSB], [http://www.ebi.ac.uk/pdbsum/3fj6 PDBsum]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Defects in DHODH are the cause of postaxial acrofacial dysostosis (POADS) [MIM:[http://omim.org/entry/263750 263750]]; also known as Miller syndrome. POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.<ref>PMID:19915526</ref>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.
		+	== Evolutionary Conservation ==
		+	[[Image:Consurf_key_small.gif\|200px\|right]]
		+	Check<jmol>
		+	<jmolCheckbox>
		+	<scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/fj/3fj6_consurf.spt"</scriptWhenChecked>
		+	<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
		+	<text>to colour the structure by Evolutionary Conservation</text>
		+	</jmolCheckbox>
		+	</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary\|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/chain_selection.php?pdb_ID=2ata ConSurf].
		+	<div style="clear:both"></div>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Pyrimidine biosynthesis is an attractive drug target in a variety of organisms, including humans and the malaria parasite Plasmodium falciparum. Dihydroorotate dehydrogenase, an enzyme catalyzing the only redox reaction of the pyrimidine biosynthesis pathway, is a well-characterized target for chemotherapeutical intervention. In this study, we have applied SPROUT-LeadOpt, a software package for structure-based drug discovery and lead optimization, to improve the binding of the active metabolite of the anti-inflammatory drug leflunomide to the target cavities of the P. falciparum and human dihydroorotate dehydrogenases. Following synthesis of a library of compounds based upon the SPROUT-optimized molecular scaffolds, a series of inhibitors generally showing good inhibitory activity was obtained, in keeping with the SPROUT-LeadOpt predictions. Furthermore, cocrystal structures of five of these SPROUT-designed inhibitors bound in the ubiquinone binding cavity of the human dihydroorotate dehydrogenase are also analyzed.

-	~~==Disease==~~	+	Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases.,Davies M, Heikkila T, McConkey GA, Fishwick CW, Parsons MR, Johnson AP J Med Chem. 2009 May 14;52(9):2683-93. PMID:19351152<ref>PMID:19351152</ref>
-	[[http://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Defects in DHODH are the cause of postaxial acrofacial dysostosis (POADS) [MIM:[http://omim.org/entry/263750 263750]]; also known as Miller syndrome. POADS is characterized by severe micrognathia, ~~cleft lip~~ and~~/or palate, hypoplasia or aplasia~~ of ~~the posterior elements~~ of ~~the limbs, coloboma of the eyelids~~ and ~~supernumerary nipples~~. ~~POADS is a very rare disorder: only 2 multiplex families~~, ~~each consisting of 2 affected siblings born to unaffected~~, ~~nonconsanguineous parents~~, ~~have been described among a total of around 30 reported cases~~.<ref>PMID:~~19915526~~</ref>	+
-		+
-	~~==Function==~~	+
-	~~[[http://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.~~	+

-	~~==About this Structure==~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	~~[[3fj6]] is~~ a ~~1 chain structure with sequence from [http://en~~.~~wikipedia~~.~~org/wiki/Homo_sapiens Homo sapiens]~~. ~~Full crystallographic information is available from [http:~~/~~/oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA].~~	+	</div>

-	==~~Reference~~==	+	==See Also==
-	~~<ref group~~=~~"xtra">PMID:019351152</ref>~~<references ~~group="xtra"~~/><~~references~~/>	+	*[[Dihydroorotate dehydrogenase\|Dihydroorotate dehydrogenase]]
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
	[[Category: Dihydroorotate oxidase]]		[[Category: Dihydroorotate oxidase]]
	[[Category: Homo sapiens]]		[[Category: Homo sapiens]]
-	[[Category: Heikkila, T.]]	+	[[Category: Heikkila, T]]
	[[Category: Alpha-beta barrel tim barrel]]		[[Category: Alpha-beta barrel tim barrel]]
	[[Category: Fad]]		[[Category: Fad]]

OCA at 02:29, 25 March 2013

2013-03-25T02:29:35Z

←Older revision		Revision as of 02:29, 25 March 2013
Line 1:		Line 1:
-	[[Image:3fj6.png\|left\|200px]]
-
	{{STRUCTURE_3fj6\| PDB=3fj6 \| SCENE= }}		{{STRUCTURE_3fj6\| PDB=3fj6 \| SCENE= }}
-
	===Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2===		===Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2===
		+	{{ABSTRACT_PUBMED_19351152}}

-	~~{{ABSTRACT_PUBMED_19351152}}~~	+	==Disease==
		+	[[http://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Defects in DHODH are the cause of postaxial acrofacial dysostosis (POADS) [MIM:[http://omim.org/entry/263750 263750]]; also known as Miller syndrome. POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.<ref>PMID:19915526</ref>
		+
		+	==Function==
		+	[[http://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.

	==About this Structure==		==About this Structure==
Line 11:		Line 13:

	==Reference==		==Reference==
-	<ref group="xtra">PMID:019351152</ref><references group="xtra"/>	+	<ref group="xtra">PMID:019351152</ref><references group="xtra"/><references/>
	[[Category: Dihydroorotate oxidase]]		[[Category: Dihydroorotate oxidase]]
	[[Category: Homo sapiens]]		[[Category: Homo sapiens]]

OCA: Protected "3fj6" [edit=sysop:move=sysop]

2013-02-13T11:22:23Z

Protected "3fj6" [edit=sysop:move=sysop]

←Older revision

Revision as of 11:22, 13 February 2013

OCA at 11:22, 13 February 2013

2013-02-13T11:22:18Z

←Older revision		Revision as of 11:22, 13 February 2013
Line 1:		Line 1:
-	~~{{Seed}}~~	+	[[Image:3fj6.png\|left\|200px]]
-	[[Image:3fj6.~~jpg~~\|left\|200px]]	+

-	<!--
-	The line below this paragraph, containing "STRUCTURE_3fj6", creates the "Structure Box" on the page.
-	You may change the PDB parameter (which sets the PDB file loaded into the applet)
-	or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-	or leave the SCENE parameter empty for the default display.
-	-->
	{{STRUCTURE_3fj6\| PDB=3fj6 \| SCENE= }}		{{STRUCTURE_3fj6\| PDB=3fj6 \| SCENE= }}

	===Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2===		===Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2===

-
-	<!--
-	The line below this paragraph, {{ABSTRACT_PUBMED_19351152}}, adds the Publication Abstract to the page
-	(as it appears on PubMed at http://www.pubmed.gov), where 19351152 is the PubMed ID number.
-	-->
	{{ABSTRACT_PUBMED_19351152}}		{{ABSTRACT_PUBMED_19351152}}

	==About this Structure==		==About this Structure==
-	~~3FJ6~~ is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA].	+	[[3fj6]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA].

	==Reference==		==Reference==
-	<ref group="xtra">PMID:~~19351152~~</ref><references group="xtra"/>	+	<ref group="xtra">PMID:019351152</ref><references group="xtra"/>
	[[Category: Dihydroorotate oxidase]]		[[Category: Dihydroorotate oxidase]]
	[[Category: Homo sapiens]]		[[Category: Homo sapiens]]
Line 34:		Line 22:
	[[Category: Mitochondrion inner membrane]]		[[Category: Mitochondrion inner membrane]]
	[[Category: Oxidoreductase]]		[[Category: Oxidoreductase]]
-	[[Category: Polymorphism]]
	[[Category: Pyrimidine biosynthesis]]		[[Category: Pyrimidine biosynthesis]]
	[[Category: Transit peptide]]		[[Category: Transit peptide]]
-
-	''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun 10 18:02:20 2009''

OCA at 15:02, 10 June 2009

2009-06-10T15:02:21Z

←Older revision		Revision as of 15:02, 10 June 2009
Line 1:		Line 1:
-	~~'''Unreleased structure'''~~	+	{{Seed}}
		+	[[Image:3fj6.jpg\|left\|200px]]

-	The ~~entry 3fj6~~ is ~~ON HOLD~~ ~~until Paper Publication~~	+	<!--
		+	The line below this paragraph, containing "STRUCTURE_3fj6", creates the "Structure Box" on the page.
		+	You may change the PDB parameter (which sets the PDB file loaded into the applet)
		+	or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
		+	or leave the SCENE parameter empty for the default display.
		+	-->
		+	{{STRUCTURE_3fj6\| PDB=3fj6 \| SCENE= }}

-	~~Authors: Davies, M., Heikkila, T.J., McConkey, G.A., Fishwick, C.W.G., Parsons, M.R., Johnson, A.P.~~	+	===Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2===

-	Description: Human dihydroorotate dehydrogenase complexed with a leflunomide derivative

-	''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed ~~Jan 7 09~~:35:10 2009''	+	<!--
		+	The line below this paragraph, {{ABSTRACT_PUBMED_19351152}}, adds the Publication Abstract to the page
		+	(as it appears on PubMed at http://www.pubmed.gov), where 19351152 is the PubMed ID number.
		+	-->
		+	{{ABSTRACT_PUBMED_19351152}}
		+
		+	==About this Structure==
		+	3FJ6 is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FJ6 OCA].
		+
		+	==Reference==
		+	<ref group="xtra">PMID:19351152</ref><references group="xtra"/>
		+	[[Category: Dihydroorotate oxidase]]
		+	[[Category: Homo sapiens]]
		+	[[Category: Heikkila, T.]]
		+	[[Category: Alpha-beta barrel tim barrel]]
		+	[[Category: Fad]]
		+	[[Category: Flavoprotein]]
		+	[[Category: Membrane]]
		+	[[Category: Mitochondrion]]
		+	[[Category: Mitochondrion inner membrane]]
		+	[[Category: Oxidoreductase]]
		+	[[Category: Polymorphism]]
		+	[[Category: Pyrimidine biosynthesis]]
		+	[[Category: Transit peptide]]
		+
		+	''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun 10 18:02:20 2009''

OCA at 07:35, 7 January 2009

2009-01-07T07:35:11Z

←Older revision		Revision as of 07:35, 7 January 2009
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 3fj6 is ON HOLD	+	The entry 3fj6 is ON HOLD until Paper Publication

	Authors: Davies, M., Heikkila, T.J., McConkey, G.A., Fishwick, C.W.G., Parsons, M.R., Johnson, A.P.		Authors: Davies, M., Heikkila, T.J., McConkey, G.A., Fishwick, C.W.G., Parsons, M.R., Johnson, A.P.
Line 7:		Line 7:
	Description: Human dihydroorotate dehydrogenase complexed with a leflunomide derivative		Description: Human dihydroorotate dehydrogenase complexed with a leflunomide derivative

-	''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed ~~Dec 31~~ 09:48:~~37 2008~~''	+	''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 7 09:35:10 2009''